share_log

Truist Securities Downgrades Axonics to Hold, Lowers Price Target to $71

Truist Securities Downgrades Axonics to Hold, Lowers Price Target to $71

Truist Securities將Axonics的評級下調至持有,將目標股價下調至71美元
Benzinga ·  01/12 15:29

Truist Securities analyst David Rescott downgrades Axonics (NASDAQ:AXNX) from Buy to Hold and lowers the price target from $73 to $71.

Truist Securities分析師戴維·雷斯科特將Axonics(納斯達克股票代碼:AXNX)的評級從買入下調至持有,並將目標股價從73美元下調至71美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論